{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:54:50Z","timestamp":1790060090659,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ajog.2025.04.044","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:37:20Z","timestamp":1745375840000},"page":"276-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"233","author":[{"given":"Ashwin","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasheenee","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline J.Y.","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki-Barbara","family":"Papalois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayushi","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Oxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin T.","family":"Fierheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka A.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamda","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Dibden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Blyuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Legood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-5057","authenticated-orcid":false,"given":"Ranjit","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.04.044_bib1","series-title":"Cancer Tomorrow. A tool that predicts the future cancer incidence and mortality burden worldwide from the current estimates in 2018 up until 2040","author":"Cancer","year":"2018"},{"key":"10.1016\/j.ajog.2025.04.044_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.22.01549","article-title":"Overall survival with maintenance olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: the SOLO1\/GOG 3004 trial","volume":"41","author":"DiSilvestro","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib3","series-title":"Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer","year":"2023"},{"key":"10.1016\/j.ajog.2025.04.044_bib4","series-title":"Technology appraisal guidance TA709","article-title":"Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency","year":"2021"},{"key":"10.1016\/j.ajog.2025.04.044_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ijgc-2020-002112","article-title":"British Gynaecological Cancer Society\/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1\/2 variants in ovarian cancer in the United Kingdom","volume":"31","author":"Sundar","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.04.044_bib6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.19.02960","article-title":"Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline","volume":"38","author":"Konstantinopoulos","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib7","series-title":"Ovarian cancer: identifying and managing familial and genetic risk [NG241]","year":"2024"},{"key":"10.1016\/j.ajog.2025.04.044_bib8","series-title":"Diagnostics guidance [DG42]","article-title":"Testing strategies for Lynch syndrome in people with endometrial cancer","year":"2020"},{"key":"10.1016\/j.ajog.2025.04.044_bib9","series-title":"SGO Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer","year":"2014"},{"key":"10.1016\/j.ajog.2025.04.044_bib10","series-title":"Diagnostics guidance [DG27]","article-title":"Molecular testing strategies for Lynch syndrome in people with colorectal cancer","year":"2017"},{"key":"10.1016\/j.ajog.2025.04.044_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2014.186","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society task force on colorectal cancer","volume":"109","author":"Giardiello","year":"2014","journal-title":"Off J Am Col Gastroenterology | ACG"},{"key":"10.1016\/j.ajog.2025.04.044_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/srep29506","article-title":"Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients","volume":"6","author":"George","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.ajog.2025.04.044_bib13","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/ijgc-2019-000389","article-title":"Uptake of testing for germline BRCA mutations in patients with non-mucinous epithelial ovarian cancers in Western Australia: a comparison of different genetic counseling methods","volume":"29","author":"Stearnes","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.04.044_bib14","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.3390\/cancers13174344","article-title":"Implementation of multigene germline and parallel somatic genetic testing in epithelial ovarian cancer: SIGNPOST study","volume":"13","author":"Chandrasekaran","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajog.2025.04.044_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/JU.0000000000002865","article-title":"Satisfaction with clinician-led germline genetic counseling in patients with prostate cancer","volume":"208","author":"Abusamra","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.ajog.2025.04.044_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/curroncol28020138","article-title":"A comparison of patient-reported outcomes following consent for genetic testing using an oncologist- or genetic counselor-mediated model of care","volume":"28","author":"McCuaig","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ajog.2025.04.044_bib18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1200\/JCO.2017.76.2781","article-title":"Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer","volume":"36","author":"Colombo","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4428","article-title":"Evaluation of cancer-based criteria for Use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer","volume":"2","author":"Kemp","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2025.04.044_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/ijgc-2019-000384","article-title":"The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)","volume":"29","author":"Enomoto","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.04.044_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/cancers12020338","article-title":"Oncology clinic-based hereditary cancer genetic testing in a population-based health care system","volume":"12","author":"Richardson","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajog.2025.04.044_bib22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3390\/jcm9061842","article-title":"Feasibility of Gynaecologist led Lynch syndrome testing in women with endometrial cancer","volume":"9","author":"Ryan","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajog.2025.04.044_bib23","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41598-020-60149-5","article-title":"Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: a study of 255 patients and its impact on their management","volume":"10","author":"Rumford","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2025.04.044_bib24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/ijgc-2020-001261","article-title":"BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral","volume":"30","author":"Piedimonte","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.04.044_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2020.07.027","article-title":"Streamlining genetic testing for women with ovarian cancer in a Northern California health care system","volume":"159","author":"Powell","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib26","article-title":"Effects of initiating physician-performed germline testing in safety net clinic patients with epithelial overian cancer","volume":"34","author":"Jordan","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ajog.2025.04.044_bib27","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41436-021-01262-2","article-title":"Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer","volume":"23","author":"Hamilton","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2025.04.044_bib28","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1200\/OP.20.00399","article-title":"Evaluation of a mainstream model of genetic testing for men with prostate cancer","volume":"17","author":"Scheinberg","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ajog.2025.04.044_bib29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3332\/ecancer.2021.1283","article-title":"Feasibility of genetic testing for cancer risk assessment programme in Nigeria","volume":"15","author":"Adejumo","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ajog.2025.04.044_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jmedgenet-2020-107416","article-title":"Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes","volume":"59","author":"Yoon","year":"2022","journal-title":"J Med Genet"},{"key":"10.1016\/j.ajog.2025.04.044_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4143\/crt.2021.978","article-title":"Implication and Influence of multigene panel testing with genetic counseling in Korean patients with BRCA1\/2 mutation-negative breast cancer","volume":"54","author":"Park","year":"2022","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ajog.2025.04.044_bib32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pros.24327","article-title":"Hereditary cancer risk assessment and genetic testing in the community urology practice setting","volume":"82","author":"Shore","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.ajog.2025.04.044_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13053-022-00238-w","article-title":"Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing","volume":"20","author":"Bokkers","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.ajog.2025.04.044_bib34","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.3390\/curroncol29050288","article-title":"Patient experience with a gynecologic oncology-initiated genetic testing model for women with Tubo-ovarian cancer","volume":"29","author":"Sadinsky","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5694\/mja2.51906","article-title":"Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care","volume":"218","author":"De Silva","year":"2023","journal-title":"Med J Aust"},{"key":"10.1016\/j.ajog.2025.04.044_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.breast.2023.03.017","article-title":"Patients' experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: results from a large prospective multicenter study","volume":"69","author":"Bokkers","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.ajog.2025.04.044_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1245\/s10434-023-14394-3","article-title":"Universal germline-genetic testing for breast cancer: implementation in a rural practice and impact on shared decision-Making","volume":"31","author":"Shelton","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ajo.13650","article-title":"Mainstream genetic testing for high-grade ovarian, tubal and peritoneal cancers: a tertiary referral centre experience","author":"Srinivasa","year":"2023","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2025.04.044_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10689-022-00313-0","article-title":"A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and\/or ovarian cancer in three tertiary cancer centres in Ireland","volume":"22","author":"McVeigh","year":"2023","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ajog.2025.04.044_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2024.03.005","article-title":"Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake","volume":"183","author":"Byrne","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib41","article-title":"BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial","author":"Torr","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.ajog.2025.04.044_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ajmg.1320370419","article-title":"Satisfaction with genetic counseling: dimensions and measurement","volume":"37","author":"Shiloh","year":"1990","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2025.04.044_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/B:JOGC.0000035523.96133.bc","article-title":"Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale","volume":"13","author":"DeMarco","year":"2004","journal-title":"J Genet Couns"},{"key":"10.1016\/j.ajog.2025.04.044_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0272989X9501500105","article-title":"Validation of a decisional conflict scale","volume":"15","author":"O'Connor","year":"1995","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajog.2025.04.044_bib45","author":"AM"},{"key":"10.1016\/j.ajog.2025.04.044_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ajog.2025.04.044_bib47","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/pon.3485","article-title":"Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics","volume":"23","author":"Eijzenga","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.ajog.2025.04.044_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","article-title":"The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI)","volume":"31","author":"Marteau","year":"1992","journal-title":"Br J Clin Psychol"},{"key":"10.1016\/j.ajog.2025.04.044_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1188\/17.ONF.329-336","article-title":"The distress thermometer: Cutoff points and clinical use","volume":"44","author":"Cutillo","year":"2017","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.ajog.2025.04.044_bib50","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/pon.5908","article-title":"Validation of the multidimensional impact of cancer risk assessment questionnaire to assess impact of waiting for genome sequencing results","volume":"31","author":"Best","year":"2022","journal-title":"Psychooncology"},{"issue":"Suppl 11","key":"10.1016\/j.ajog.2025.04.044_bib51","first-page":"S467","article-title":"Measures of anxiety: state-Trait anxiety Inventory (STAI), Beck anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A)","volume":"63","author":"Julian","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ajog.2025.04.044_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ajco.13334","article-title":"Mainstream consent programs for genetic counseling in cancer patients: a systematic review","volume":"17","author":"Scheinberg","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/cancers14041059","article-title":"The feasibility of implementing mainstream germline genetic testing in routine cancer care-A systematic review","volume":"14","author":"Bokkers","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajog.2025.04.044_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12687-015-0256-y","article-title":"Wide disparity of clinical genetics services and EU rare disease research funding across Europe","volume":"7","author":"Lynch","year":"2016","journal-title":"J Community Genet"},{"key":"10.1016\/j.ajog.2025.04.044_bib55","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41436-018-0417-6","article-title":"Current conditions in medical genetics practice","volume":"21","author":"Maiese","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2025.04.044_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1245\/s10434-024-16223-7","article-title":"Mainstream germline genetic testing with expanded eligibility for early breast cancer patients in a large Integrated health system","volume":"32","author":"Shim","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2025.04.044_bib58","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41436-020-0785-6","article-title":"Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care","volume":"22","author":"White","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2025.04.044_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/pme-2021-0096","article-title":"Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review","volume":"19","author":"Rahman","year":"2022","journal-title":"Per Med"},{"key":"10.1016\/j.ajog.2025.04.044_bib60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10689-019-00122-y","article-title":"Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care","volume":"18","author":"Hallowell","year":"2019","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ajog.2025.04.044_bib61","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41431-021-00871-4","article-title":"Stakeholders' views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology","volume":"29","author":"O'Shea","year":"2021","journal-title":"Eur J Hum Genet"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825002595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825002595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:32:41Z","timestamp":1761431561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825002595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002937825002595"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.04.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}